1. Wang, Xueying, Dong, Jiani, Li, Xiaojing, Cheng, Zeneng, Zhu, Qubo. 2021. CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma. In Oncogene, 40, 4338-4351. doi:10.1038/s41388-021-01867-6. https://pubmed.ncbi.nlm.nih.gov/34103682/
2. Lee, Kaping, Zheng, Qiufan, Lu, Qianyi, Deng, Wuguo, Wang, Shusen. 2021. CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4. In Signal transduction and targeted therapy, 6, 184. doi:10.1038/s41392-021-00565-9. https://pubmed.ncbi.nlm.nih.gov/34006850/
3. Song, YingQiu, Sun, Kai, Gong, LiLan, Zheng, FeiMeng, Li, GuiLing. 2022. CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer. In Medical oncology (Northwood, London, England), 40, 62. doi:10.1007/s12032-022-01919-1. https://pubmed.ncbi.nlm.nih.gov/36567417/
4. Bergant, Valter, Schnepf, Daniel, de Andrade Krätzig, Niklas, Staeheli, Peter, Pichlmair, Andreas. 2023. mRNA 3'UTR lengthening by alternative polyadenylation attenuates inflammatory responses and correlates with virulence of Influenza A virus. In Nature communications, 14, 4906. doi:10.1038/s41467-023-40469-6. https://pubmed.ncbi.nlm.nih.gov/37582777/
智鼠故事 
